HCA Healthcare Inc
NYSE:HCA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
246.65
415.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
HCA Healthcare Inc
Cash & Cash Equivalents
HCA Healthcare Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
HCA Healthcare Inc
NYSE:HCA
|
Cash & Cash Equivalents
$2.9B
|
CAGR 3-Years
41%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
||
Universal Health Services Inc
NYSE:UHS
|
Cash & Cash Equivalents
$106.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
||
Encompass Health Corp
NYSE:EHC
|
Cash & Cash Equivalents
$147.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-6%
|
||
Select Medical Holdings Corp
NYSE:SEM
|
Cash & Cash Equivalents
$191.5m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
7%
|
CAGR 10-Years
33%
|
||
Tenet Healthcare Corp
NYSE:THC
|
Cash & Cash Equivalents
$4.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
67%
|
CAGR 10-Years
35%
|
||
Ensign Group Inc
NASDAQ:ENSG
|
Cash & Cash Equivalents
$532.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
64%
|
CAGR 10-Years
30%
|
HCA Healthcare Inc
Glance View
HCA Healthcare Inc. stands as one of the largest publicly traded hospital operators in the United States, boasting a robust network of over 450 facilities, which includes hospitals, outpatient centers, and emergency rooms. Founded in 1968, the company has consistently demonstrated a strong commitment to delivering quality healthcare services while ensuring operational efficiency. With a patient-centric approach, HCA has leveraged advanced technology and data analytics to enhance patient outcomes and streamline processes. This focus on quality care has not only fortified its reputation among patients but also positioned HCA favorably within the highly competitive healthcare landscape. As investors look toward HCA Healthcare, they will find a company that marries growth potential with stability. The firm has consistently outperformed market expectations, driven by a rising demand for healthcare services amid an aging population and increasing prevalence of chronic conditions. HCA’s strategic expansion into new markets and its investments in innovative healthcare models signify its resilience and adaptability in a rapidly evolving industry. With a strong financial footing, impressive profit margins, and a commitment to returning value to shareholders, HCA Healthcare presents a compelling case for those seeking long-term investment opportunities in the healthcare sector.
See Also
What is HCA Healthcare Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.9B
USD
Based on the financial report for Sep 30, 2024, HCA Healthcare Inc's Cash & Cash Equivalents amounts to 2.9B USD.
What is HCA Healthcare Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
19%
Over the last year, the Cash & Cash Equivalents growth was 224%. The average annual Cash & Cash Equivalents growth rates for HCA Healthcare Inc have been 41% over the past three years , 39% over the past five years , and 19% over the past ten years .